Define Ventures is an early-stage venture capital firm solely focused on investing in digital health companies. They partner with entrepreneurs with the digital health focus and expertise that they deserve to redefine healthcare.

Define Ventures

Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, is dedicated to forming effective partnerships with innovative companies. Kaiser Permanente Ventures invests predominantly in HCIT and services, as well as diagnostics, drug delivery and therapeutic medical devices.

Kaiser Permanente Ventures

Providence Ventures generally targets mid-to late-stage venture investments across Healthcare IT, MedTech, and tech-enabled services. Over the life of an investment, they seek to deploy $8 to $15 million. Their best opportunities to add value are investments that align the interests of their portfolio companies and the innovation priorities of Providence Health & Services, through broad solution deployment and strategic insight. The innovation opportunities PHS targets as a large health system tend to reflect the priorities of the US health system overall. They welcome the opportunity to partner with established venture funds as co-investors, however, syndication is not a prerequisite for their participation. Providence Ventures is founded in 2014 which manages $300 million in venture capital funds on behalf of Providence St. Joseph Health (PSJH), one of the largest integrated health systems in the US. The company's​ mission is to achieve venture and growth equity class returns through direct investments in innovative healthcare companies that improve health outcomes, lower costs, and enhance the experience of our patients and caregivers. It offers investment capital, combined with health system expertise, to companies addressing existing and emerging pain points in healthcare. Providence Ventures partners with our portfolio companies to refine existing solutions, while expanding their adoption within and beyond our health system.

Providence Ventures

Frist Cressey Ventures is focused on accelerating the growth of high potential healthcare enterprises through value-added partnerships.  We invest in technology and service businesses with viable solutions that improve quality of care, system integration, patient outcomes, and population health and wellbeing.  We join like-minded entrepreneurs who share similar core values in their pursuit to improve healthcare.

Frist Cressey Ventures

SpringRock Ventures is a venture capital firm that helps entrepreneurs building compelling companies in an evolving sector. The venture capital firm focuses on digital health, devices, services, oral health, SAAS, consumerization/eCommerce of healthcare, IT, wellness, HIPAA and other innovative companies improving general health. They invest in early to late-stage, high growth-potential companies with some demonstrated customer acceptance.  SpringRock Ventures was founded in 2015 and is based in Seattle, Washington, USA.

SpringRock Ventures

Transformation Capital is the successor management company to Leerink Transformation Partners LLC (“LTP”).11  LTP was founded in 2016 by Todd Cozzens and Jared Kesselheim, MD together with SVB Leerink Capital LLC (formerly Leerink Capital Partners LLC) (“Leerink Capital”), an affiliate of SVB Leerink LLC (“Leerink”), a leading healthcare investment bank.  Leerink Capital provided seed capital to Fund I (approximately 3% of capital commitments) and operational support. In January 2019, SVB Financial Group (“SVB”), the holding company of Silicon Valley Bank, a U.S.-based high-tech commercial bank, acquired the Leerink businesses including Leerink Capital.  Todd Cozzens, Jared Kesselheim, MD, and SVB expect to agree to a mutually beneficial ongoing relationship in which Transformation Capital (as an independent management company owned by Todd Cozzens, Jared Kesselheim, MD, and Michael Dixon and not affiliated with SVB or Leerink Capital) shall manage Fund II and whereby Transformation Capital shall manage Fund I’s investment portfolio pursuant to a sub-advisory agreement with SVB (or an affiliate).  Transformation Capital has the same operational leader, Kevin Brown, formerly CFO of Leerink Capital, and Transformation Capital expects to continue to derive benefits from its ongoing relationship with Leerink and SVB.

Transformation Capital

Kaiser Permanente, commonly known simply as Kaiser, is an American integrated managed care consortium, based in Oakland, California, United States, founded in 1945 by industrialist Henry J. Kaiser and physician Sidney Garfield. Kaiser Permanente is made up of three distinct but interdependent groups of entities: the Kaiser Foundation Health Plan, Inc. (KFHP) and its regional operating subsidiaries; Kaiser Foundation Hospitals; and the regional Permanente Medical Groups. As of 2017, Kaiser Permanente operates in eight states (Hawaii, Washington, Oregon, California, Colorado, Maryland, Virginia, Georgia) and the District of Columbia, and is the largest managed care organization in the United States. Kaiser Permanente is one of the largest nonprofit healthcare plans in the United States, with over 12 million members. It operates 39 hospitals and more than 700 medical offices, with over 300,000 personnel, including more than 87,000 physicians and nurses. Each Permanente Medical Group operates as a separate for-profit partnership or professional corporation in its individual territory, and while none publicly reports its financial results, each is primarily funded by reimbursements from its respective regional Kaiser Foundation Health Plan entity. KFHP is one of the largest not-for-profit organizations in the United States. KP's quality of care has been highly rated and attributed to an emphasis on preventive care, its doctors being salaried rather than paid on a fee-for-service basis, and an attempt to minimize the time patients spend in high-cost hospitals by carefully planning their stay. However, Kaiser has had disputes with its employees' unions; repeatedly faced civil and criminal charges for falsification of records and patient dumping; faced action by regulators over the quality of care it provided, especially to patients with mental health issues; and faced criticism from activists and action from regulators over the size of its cash reserves.

Kaiser Permanente

Mass General Brigham Ventures is the venture capital arm of Mass General Brigham that invests in early-stage companies. The primary mission of MGB Ventures is to accelerate the translation of innovative research and technology developed within the Mass General Brigham system into commercial solutions that can significantly improve patient care and healthcare delivery.

Mass General Brigham Ventures

ICONIQ Growth partners with exceptional entrepreneurs and leaders who drive global impact and change. The firm is inspired by visionaries defining the future of their industries by building company cultures that endure. ICONIQ Growth has a unique investment platform harnesses the power of ICONIQ Capital’s vibrant ecosystem of founders, pioneers, and business leaders with the goal of delivering tangible value and amplifying our portfolio companies’ success from early growth stage to IPO and beyond. ICONIQ Growth’s portfolio of innovators includes Adyen, AirBnB, Alibaba, Alteryx, Automattic, BambooHR, Braze, Chime, Collibra, Coupa, Datadog, Docusign, Gitlab, Marqeta, Miro, Procore, Red Ventures, Relativity, ServiceTitan, Snowflake, Sprinklr, Truckstop, Uber, Wolt, and Zoom, among others.

ICONIQ Growth

DexCare

DexCare is a provider of platform-as-a-service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform them into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

<div><p>Seattle-based DexCare is a healthcare technology company that offers providers a platform to optimize their healthcare operations. Primarily, the platform enables healthcare providers to provide virtual care through virtual consultations, online scheduling, urgent care, and specialist consultations.</p></div>

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

<div><p>DexCare is a provider of Platform-as-a-Service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform into a highly scalable digital experience for their patients&mdash; increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.</p></div>

Simplifying healthcare administration with intuitive tech tools

Hospital Management

DexCare Announces Additional Investors

<div>
  <p>
    Seattle-based DexCare is a healthcare technology company that offers providers a platform to optimize their healthcare operations. Primarily, the platform enables healthcare providers to provide virtual care through virtual consultations, online scheduling, urgent care, and specialist consultations. 
  </p>
  <p>
    The platform additionally helps healthcare providers better sell their services through offering value added services such as digital discovery services, to help healthcare providers capture more customers, and care navigation solutions, to help patients find relevant care services with more ease while engaging in a &ldquo;shoppable&rdquo; experience.
  </p>
  <p>
  </p>
  <p>
    <b>Funding and financials</b>
  </p>
  <p>
    In June 2023, the company raised USD 75 million in a Series C funding round led by ICONIQ Growth, along with participation from other venture capital firms. The raised funds were set aside to develop the company&rsquo;s platform further.&nbsp;
  </p>
  <p>
  </p>
  <p>
  </p>
</div>


<div>
  <p>
    Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
  </p>
  <p>
    In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
  </p>
  <p>
  </p>
</div>


Nice Healthcare

<p><span>Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications.</span></p><p><span>Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.</span></p>

Amicomed

<p><span>Winston is a men’s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients.</span></p><p><span>The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.</span></p>

Winston

<p><span>Eko Health is a digital health company that has developed an AI-powered platform for detecting heart and lung diseases during routine physical examinations. The company's flagship product, SENSORA, comprises digital stethoscopes integrated with advanced algorithms that can identify structural heart murmurs, low ejection fraction (indicative of heart failure), and atrial fibrillation.</span></p>
<p><span>In June 2024, Eko Health raised USD 41 million in a Series D funding round to scale its disease detection platform globally. The company's murmur detection algorithm, cleared by the FDA, was clinically validated in a study at Massachusetts General Hospital, demonstrating a two-fold increase in identifying structural heart murmurs compared to standard practice. Furthermore, Eko's low ejection fraction algorithm, developed in collaboration with Mayo Clinic, significantly improved the detection of heart failure with reduced ejection fraction in a study conducted at Imperial College London.</span></p>
<p><span>Eko Health's technology aims to reduce diagnostic bottlenecks and enhance patient outcomes by facilitating early detection of cardiac and pulmonary diseases. With over 500,000 healthcare professionals utilizing its FDA-cleared platform worldwide as of June 2024, the company has established a substantial presence in the market.</span></p>
<p><span>In June 2023, Eko Health launched its next-generation digital stethoscope, CORE 500, featuring advanced capabilities such as a full-color display, 3-lead electrocardiogram (ECG), and TrueSound technology for optimal sound filtering. The CORE 500 received FDA 510(k) clearance and seamlessly integrates with the SENSORA platform.</span></p>
<p><b><strong>Key customers and partnerships</strong></b></p>
<p><span>In November 2023, Eko Health announced a large-scale deployment of its AI-enabled technology through the TRICORDER program, an implementation initiative led by Imperial College London and funded by the National Institute for Health and Care Research (NIHR). The program aims to deploy Eko's technology to 100 General Practitioner (GP) practices across the UK, assisting clinicians in evaluating heart failure, valvular heart disease, and atrial fibrillation.</span></p>
<p><span>Additionally, Eko Health has partnered with leading academic institutions such as Massachusetts General Hospital and Mayo Clinic to validate the clinical utility and positive impact of its technology on patient care.</span></p>
<p><br></p>

Eko Health

<div>
  <p>
    Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
  </p>
  <p>
    The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care,  wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
  </p>
  <p>
    <b>Key Customers and partnerships</b>
  </p>
  <p>
    Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
  </p>
  <p>
    <b>Fundings and financials</b>
  </p>
  <p>
    As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
  </p>
  <p>
    In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
    an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
     
    Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
    <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
      <u>acquired by financial services company Sun Life Financial</u>
    </a>
     for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
  </p>
  <p>
  </p>
</div>


Dialogue

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates. 


A platform that facilitates the transmission of patient data to different locations for further evaluation and interpretation by medical specialists. 


A digital platform that offers specialty care services to address the specific needs of a patient or demographic, including consultations where patients are generally reluctant to meet practitioners face-to-face.

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

Companies developing B2B software solutions for patient engagement, care navigation, practice management, and electronic health records integration to facilitate telehealth services for healthcare providers. 

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

<div>
  <p>
    DexCare is a provider of Platform-as-a-Service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform into a highly scalable digital experience for their patients&mdash; increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.
  </p>
</div>


<div>
  <p>
    ModMed is transforming healthcare by placing doctors and patients at the center of care through an intelligent, specialty-specific cloud platform. Their specialty-specific, data-driven, and cloud-based electronic health records (EHR) and practice management (PM) systems, plus revenue cycle management (RCM) services, were built by a team including specialty physicians and practice management professionals.
  </p>
</div>


Modernizing Medicine

<div>
  <p>
    Kyruus delivers proven provider search and scheduling solutions that help hospitals and health systems match patients with the providers best suited to care for them. The ProviderMatch suite of solutions&mdash;for consumers, access centers, and referral networks&mdash;enables a consistent patient experience across multiple points of access, while aligning provider supply with patient demand. The company&rsquo;s proprietary provider data management platform forms the foundation of its solutions, powering them with accurate data by coupling data processing with administrative applications. Kyruus was founded in 2010 and is headquartered in Boston, Massachusetts.
  </p>
</div>


Kyruus

<div>
  <p>
    AKASA is an AI-powered automation company for revenue cycle management in healthcare. The company provides hospitals with Unified Automation services, which is a flexible AI-based solution that automates complex operational tasks such as those related to revenue cycle management. Its approach imbues the entire automation process with human judgment and subject matter expertise. Unified Automation operates within a hospital's existing electronic health record (EHR) and revenue cycle infrastructure to reduce errors and improve efficiencies.
  </p>
</div>


AKASA

<div>
  <p>
    XSOLIS is a healthcare technology firm focused on improving healthcare operations through cognitive computing. By aligning cognitive computing behind clinical expertise, we're creating a new framework for decision-making.
  </p>
</div>


XSOLIS

<div>
  <p>
    Suki is an AI-powered, voice-enabled digital assistant for doctors. It was designed to help healthcare organizations with their administrative tasks. Suki helps physicians in dictating notes, retrieving info, and working with EHR. The company was founded in 2017 and is headquartered in Redwood City, California.
  </p>
</div>


Suki

Platforms used by hospitals to manage the various aspects of patient care to improve overall efficiency, such as automating routine tasks, improving communication and coordination among healthcare providers, and enhancing patient outcomes within the hospital setting

Platforms that enable patients to actively participate in their healthcare journey by educating and engaging them, along with improving communication with healthcare providers

Platforms that help healthcare organizations analyze patient data and other performance metrics to improve decision-making and optimize resource allocation

Platforms that are designed to help hospitals and health systems manage their financial operations from patient billing and insurance claims to revenue tracking and analysis

AI-powered software solutions that are designed to help healthcare organizations streamline and automate the process of documenting patient encounters

IoT medical solutions turn traditional hospitals into smart hospitals, allowing them to streamline workflows

AI/ML algorithms optimize workflows, enable predictive modeling, and analyze patient data in healthcare

Offers software platforms that streamline and improve hospital operations

DexCare

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless